Outlook Therapeutics (NASDAQ:OTLK) Stock, Earnings Estimates, EPS, And Revenue

Outlook Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Dec 20
EPS Estimate
$-0.850
Quarterly Revenue Estimate
Annual Revenue
(as of Jun 30)

Analyze the earnings history of Outlook Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Outlook Therapeutics (OTLK) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-14$-0.83$-1.0117.8 %
Mar 20242024-05-15$-1.55$-0.85-82.3 %
Jun 20232023-08-14$-1.60$-1.00-60.0 %
Mar 20232023-05-15$-0.60$-1.2050.0 %

Outlook Therapeutics (OTLK) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20212021-12-22$0$300.00K-100.0 %
Jun 20212021-08-13$0$320.00K-100.0 %
Mar 20212021-05-14$0$320.00K-100.0 %

FAQ

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics (OTLK) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on August 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Outlook Therapeutics (NASDAQ:OTLK)?

A

The Actual EPS was $-0.83, which beat the estimate of $-1.01.

Q

What were Outlook Therapeutics’s (NASDAQ:OTLK) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch